| abstract |
The present invention provides a compound of formula (I) and a pharmaceutically acceptable thereof for use in therapy alone or in combination with one or more other pharmaceutically active compounds for the treatment of diseases associated with deregulated angiogenesis, eg cancer. It relates to salts, hydrates or solvates.n n n Formula In n n n n n n n In Formula I above,n n n D, E, F, G, W, Y, R 1 , A, R 9 , X, B or R 8 are as described herein. |